Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_assertion evidence source_evidence_literature NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_assertion SIO_000772 25193384 NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_assertion wasDerivedFrom befree-20150227 NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_assertion wasGeneratedBy ECO_0000203 NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.